
Loading, please wait...

Loading, please wait...

Clinicians often encounter limited high-quality evidence regarding homeopathy for hemorrhoids, despite its widespread traditional use in various clinical settings. However, a recent double-blind, randomized, placebo-controlled trial offers new data on the efficacy of individualized homeopathic medicinal products (IHMPs). Researchers conducted this study at a tertiary homeopathic hospital in West Bengal, India, involving 134 adults diagnosed with grade I-III hemorrhoids.
During the three-month study period, participants received either IHMPs or an identical-looking placebo. Notably, both groups adhered to standard concomitant care, which included dietary modifications, sitz baths, and pelvic floor exercises. The primary analysis focused on the change in the Anorectal Symptom Severity and Quality-of-Life (ARSSQoL) total score. Consequently, the findings highlighted significant differences between the intervention and control groups.
After three months, the group receiving IHMPs demonstrated significantly greater improvement than the placebo group. Specifically, the mean group difference in the ARSSQoL total score was -6.5. Furthermore, secondary outcomes involving quality-of-life scales and numeric rating scales also favored the homeopathic treatment. Importantly, patients tolerated the individualized remedies well, and no serious adverse events occurred throughout the trial. Therefore, these results suggest that individualized homeopathy can serve as an effective adjunct to standard conservative management for symptomatic relief.
According to this randomized controlled trial, individualized homeopathic medicinal products significantly improved both symptom severity and quality-of-life scores compared to a placebo over a three-month period.
The study specifically included adults diagnosed with grade I, II, and III hemorrhoids. Those requiring immediate surgical intervention or suffering from grade IV disease were generally excluded from this specific primary care assessment.
The study reported that the treatment was safe and well-tolerated. No serious adverse events were documented, suggesting a high safety profile for individualized homeopathic management in the observed patient cohort.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Saha A et al. Treatment of Hemorrhoids with Individualized Homeopathic Medicinal Products: A Double-Blind, Randomized, Placebo-Controlled Trial. J Integr Complement Med. 2026 Apr 02. doi: 10.1177/27683605261435779. PMID: 41928045.
Central Council for Research in Homoeopathy. Clinical Research Guidelines in Homoeopathy. Ministry of AYUSH, Government of India.
Lohsiriwat V. Hemorrhoids: From basic pathophysiology to clinical management. World J Gastroenterol. 2012;18(17):2009-2017. doi: 10.3748/wjg.v18.i17.2009.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A randomized trial in India found that individualized homeopathic medicinal products significantly improved symptoms and quality of life in hemorrhoid patie...
6 months ago

Discover the crucial role of glymphatic dysfunction in stroke, where perivascular clearance failure and neuroinflammation exacerbate cerebral edema and post-stroke brain injury.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday